Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1

Conditions

Leukemia 27Lymphoma 25Lymphoma, Non-Hodgkin 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Multiple Myeloma 21Leukemia, Myeloid, Acute 21Hodgkin Disease 16Leukemia, Lymphocytic, Chronic, B-Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Hematologic Neoplasms 10Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Graft vs Host Disease 6Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Juvenile 5Breast Neoplasms 5Hemoglobinuria, Paroxysmal 4Rhabdoid Tumor 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Myeloid, Accelerated Phase 3Ganglioneuroblastoma 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Anemia, Aplastic 3Wilms Tumor 2Recurrence 2

Interventions

Cytarabine 3Mitoxantrone 2vosaroxin 1devimistat 1Stem Cell Transplantation 1Sorafenib 1Leyk 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Daunorubicin 1Bortezomib 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sarcoma, Myeloid × Stem Cell Transplantation × Clear all
NCT02484391 2024-09-19

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma

Wake Forest University Health Sciences

Phase 1 Completed
48 enrolled 13 charts
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡